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1. Introduction 
Recent reports [t-4] of the detection by radio- 
immunoassay of the polypeptide hormones gastrin 
and somatostatin in gastric and duodenal juice sug- 
gested the possibility of the release of pancreatic 
hormones into the lumen of the pancreatic duct. 
Indeed, preliminary studies have demonstrated the 
presence of immunoreactive pancreatic polypeptide 
in human pancreatic juice [5] and immunoreactive 
insulin and glucagon in canine pancreatic juice [8]. 
Pancreatic juice, however, contains high concentra- 
tions of proteolytic enzymes and their zymogens, that 
can damage the labeled antigen or antibody used in 
radioimmunoassays [7] and result in artifactual 
hormone immunoreactivity. This study was, there- 
fore, designed to isolate and characterize the immuno- 
reactive components of the islet hormones, insulin, 
glucagon, somatostatin and pancreatic polypeptide in 
canine pancreatic juice. 
2. Materials and methods 
Secretin was obtained from the GIH Laboratory 
(Karolinska Institute, Stockholm), the synthetic 
C-terminal octapeptide of cholecystokinin (OP-CCK) 
(Kineva@) from E. R. Squibb and Sons (Princeton, 
NJ) and phenylmethylsulphonyl fluoride from Sigma 
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Chemical Co. (St Louis, MO). 
Pancreatic juice was collected from fasted laparoto- 
mlzed dogs (N = 5) through a polyethylene cannula 
inserted in the pancreatic duct -1 cm from the duo- 
denum. Flow of juice was stimulated by a 30 min 
intravenous infusion of secretin at a dose 
(2 CU .kg-’ .h-‘) shown ]8] to produce maximal 
secretion of bicarbonate. This was followed by a 
30 min infusion of the same dose of secretin supple- 
mented with OP-CCK at a dose (0.5 pg .kg-’ Jr-‘) 
shown [8] to produce near maximal secretion of 
pancreatic enzymes. The juice from both periods of 
secretion was collected into chilled tubes containing 
acetic acid and an inhibitor of active site serine 
proteases, phenylmethylsulphonyl fluoride (0.1 ml 
of a 1% w/v solution/ml juice). The samples of juice 
were lyophilized and the residue reconstituted in 
0.1 M ammonium bicarbonate buffer (pH 8.8) con- 
taining Trasylol (I 000 K~U/ml) and EDTA (1.2 mg/ml). 
After centrifugation at 3000 rev./min for 15 min, the 
supernatant was subjected to gel filtration on columns 
(60 X 2.5 cm) of Biogel P-10 using 0.1 M ammonium 
bicarbonate buffer (pH 8.8) for elution. Eluant frac- 
tions containing immunoreactive components were 
again lyoph~ized and subjected to isoelectric focus- 
ing at 4°C in ampholine containing sucrose gra- 
dients using an LKB Model 8100 column as in [9]. 
The pH of the effluent fractions was measured at 
25’C using a Beckman Model 3550 pH meter. pI 
values at 4’C of ~munoreactive components in the 
fractions were calculated according to [lo]. Immuno- 
reactive insulin (IRI) in the chromatographic effluent 
fractions was measured by the method in [ 1 I] using 
23 
Volume 105. number 1 l:EBS LETTERS September 1979 
an antibody which reacts with both insulin and pro- 
insulin. Immunoreactive somatostatin (IRSS) was 
measured using Arimura antiserum Rl 01, which is 
directed against the central residues of somatostatin 
[ 121. Immunoreactive glucagon (IRG) was measured 
using antiserum 30K by the method in [ 131. Immuno- 
reactive pancreatic polypeptide (IRPP) was measured 
using an antiserum raised against human pancreatic 
polypeptide [ 141. 
3. Results and discussion 
Infusion of secretin resulted in an increase in flow 
of pancreatic juice from < 0.1 ml/min in the basal 
state to 0.5 + 0.2 ml/min and the flow was further 
increased to 0.8 + 0.2 ml/mm when this was supple- 
mented with OP-CCK. Infusion of OP-CCK resulted 
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Fig.1. (A) Gel filtration on Biogel P-10 columns at pH 8.8 of 
IRI from pancreatic juice after stimulation with secretin 
(shaded area) and with secretln + OPCCK (unshaded area). 
The arrows indicate the elution volumes of blue dextran (M ,), 
cytochrome c (M,), porcine insulin (M,), porcine glucagon 
(M,) and synthetic somatostatin (MS). Fractions indicated by 
( H ) were pooled, lyophilized and subjected to isoelectric 
focusing. (B) Isoelectric focusing in ampholine-containing 
sucrose gradients of IRI isolated from secretin + OP-CCK- 
stimulated pancreatic juice by gel filtration. (--) indicates 
the pH of the fractions at 25°C and ( 0 ) indicates the frac- 
tions in which porcine insulin was focused. 
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Fig.2. (A) Gel filtration on Biogel P-10 columns at pH 8.8 of 
IRSS from pancreatic juice after stimulation with secretin + 
OPCCK. The molecular weight markers are as in fig.lA and 
the fractions indicated by (t-l) were pooled, lyophillzed and 
subjected to isoelectric focusing. (B) Isoelectric focusing in 
ampholine-containing sucrose gradients of IRSS isolated from 
secretin + OP-CCK-stimulated pancreatic juice by gel filtra- 
tion. (---) indicates the pH of the fractions at 25°C and 
( &%j ) indicates the fractions in which synthetic somatostatin 
was focused. 
in a marked increase in the protein content of the 
juice in all experiments. The elution profile of the 
IRI in the juice from a representative gel filtration 
experiment is shown in fig.lA. Low levels of IRI 
were observed in the chromatograms of secretin- 
stimulated juice and this material was eluted from 
the column as a single peak with the same elution 
volume as a porcine insulin marker (shaded area). 
Infusion of OP-CCK resulted in an increase in the 
IRI content of the juice in 4 out of 5 experiments 
and this material was eluted as a broad peak with 
maximum immunoreactivity at the elution volume of 
porcine insulin (open area). The IRI in the OP-CCK- 
stimulated juice was isoelectrically focused (fig.lB) 
into a major peak in the same pH region as insulin 
(p1 5.7) and into a minor peak in the same pH region 
as proinsulii (~14.8) [ 151. 
IRSS was not observed in any sample of secretin- 
stimulated juice but was detected in OP-CCK-stim- 
ulated juice in 4 out of 5 experiments. The elution 
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profile of IRSS in the juice from a representative 
experiment is shown in fig.2A. IRSS was eluted as a 
broad, incompletely resolved peak with maximum 
immunoreactivity at the elution volume of synthetic 
somatostat~, together with a minor peak in the 
IO-12 X lo3 mol. wt zone. The major peak of 
immunoreactivity was isoelectrically focused (flg.2B) 
into a component in the same pH range as synthetic 
somatostatin (p1 10.3-10.5) together with a minor 
component at higher pH @I 10.6-10.8). While the 
predom~ant molecular form of IRSS in canine 
pancreatic tissue [9] and in plasma-free pancreatic 
venous effluent of dogs [ 161 is indistinguishable from 
synthetic somatostatin, the existence of larger and 
more basic components of IRSS in canine pancreas 
]9] and porcine gut [17] and hypo~alamus [IS] has 
been reported. 
Serial dilutions of the components of IRSS and IRI 
isolated from the pancreatic juice were proportional 
and their dilution slopes were parallel to the radio- 
immunoassay standards when incubated with antisera 
under conditions of radio~munoas~y (fig.3). It is 
concluded, therefore, that the predomin~t molecular 
forms of IRI and IRSS in pancreatic juice are indis- 
tinguishable from the corresponding components in 
pancreatic tissue with respect to molecular size, charge 
and immunometric properties. 
The rate of release of IRI into the juice was 
estimated from the area of the peaks. It rose from a 
basal 1eveI of 4.8 + 2.8 ,uU/min (mean + SEM) (range 
0.8-16 gLJ/min) during stimulation with secretin 
and to 103 I 91 pU/min (mean + SEM) (range 
-- 
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Fig.3. Dilution slopes in the radio~munoas~y of components 
of IRI and IRSS isolated from secretin + OPCCK-stimulated 
pancreatic juice by gel filtration and isoelectric focusing. 
1.4-470 pU/min) during stimulation with OP-CCK. 
The rate of release of IRSS into the OP-CCK-stimulated 
juice was estimated at 291 * 184 pg/min (mean 5 SEM) 
(range O-973 pg/min). The variation in individual 
secretory rate of the 5 dogs was very large and the 
mean rate of release in response to a pharmacological 
dose of OP-CCKrepresents< S%of the corresponding 
secretion rate of the hormones into the pancreatic 
venous effluent [ 191. 
Although radioimmunoassay of unfractionated 
pancreatic juice from both periods of secretion sug- 
gested the presence of IRG and IRPP, examination of 
the eluant fractions from the gel filtration experiments 
failed to reveal immunoreactive material with the 
same molecular size as glucagon or pancreatic poly- 
peptide in either secretin-stimulated or OP-CCK- 
stimulated juice. Serial dilutions, under radioimmuno- 
assay conditions, of the apparent IRG in the juice 
were not proportional and the IRG associated with 
the juice could not be removed by affinity chromatog- 
raphy on columns of immobilized antibodies specific 
for glucagon,prepared according to [20]. It is possible, 
therefore, that the apparent glucagon-like and pan- 
creatic polypeptidelike immunoreactivity in the juice 
results, at least in part, from non-specific interference 
in the radioimmunoassay by components in the juice. 
The source of the pancreatic hormones present in 
the juice and their physiologic si~i~c~ce, if any, is 
not apparent from these results. OP-CCK is a powerful 
stimulus for the release of IRI and IRSS [21] into 
the circulation and it is possible that the hormones in 
the juice are derived from direct flow from the islets 
to the ductules and/or derived from the endocrine 
or ‘inte~e~ate cells’ 1221 found throu~out the 
exocrine parenchyma and in the lining of the pan- 
creatic duct of a variety of species including the dog 
[23]. A recent report [24], in which intraduodenally 
instilled endogenous and exogenous secretin resulted 
in an increase in pancreatic bicarbonate secretion in 
dogs, raises the po~ib~ity the hormones in the pan- 
creatic juice may fulfill a physiological role. 
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